Stocks GWPH (GW PHARMACEUTICALS PLC)

Stock quotes GW PHARMACEUTICALS PLC (GWPH) for today

Stock chart GWPH and quotes

Financial data GW Pharmaceuticals
GW PHARMACEUTICALS PLC revenues grew 22.07% in FY 2018 compared to FY 2017 to 12.74m. Net income fell 73.16% to -295.17m.

Information about the company GW Pharmaceuticals
GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, UK. It is a biopharmaceutical company, which is currently focused on developing and marketing cannabinoid-based medicines for a range of disease areas. Key products include Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol (CBD), and Sativex (nabiximols), which is used for the treatment of spasticity due to multiple sclerosis (MS). The Company operates through three segments: Commercial, Sativex Research and Development, and Pipeline Research and Development. Follow the GWPH instrument to learn all about the latest news and developments.

Company statistics GW Pharmaceuticals
Sector: Healthcare Industry: Biotechnology & Medical Research Employees: 791

Start trading

Risk disclaimer "Market Solutions Ltd – Suite 305 Griffith Corporate Centre P.O. Box 1510 Beachmont, Kingstown, St Vincent and the Grenadines is a financial services institution outside the European Union Area, which is subject to the supervision of the IFMRRC Certificate 0395 AA V0128 Trading in Forex/ CFDs and Other Derivatives is highly speculative and carries a high level of risk. It is possible to lose all your capital. 70% of trading deals can be unprofitable. These products may not be suitable for everyone and you should ensure that you understand the risks involved. Seek independent advice if necessary. Speculate only with funds that you can afford to lose. This Website may contain information in particular regarding financial services and products that could be regarded b a E.U. supervisory authority as an offer of financial services targeted in Europe. ESMA intervention measures do not apply to customers of Market solutions Ltd and it is your responsibility to choose a company which is most suitable for your trading needs. By clicking continue you confirm that you have read, understood and agree to the risk disclosures, terms of service, cash policies, privacy policies and this notice and that you are visiting this website on your own initiative, without any encouragement whatsoever from Umarkets.com or Market Solutions limited." Cookies notification: “We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we assume that you are happy with it. Continue